Bio Path Holdings Inc BPTH:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
2.61UNCH (UNCH)
Volume
1,912
Close
2.61quote price arrow down-0.05 (-1.88%)
Volume
265,748
52 week range
2.35 - 44.80
Loading...
  • Open2.55
  • Day High2.82
  • Day Low2.50
  • Prev Close2.66
  • 52 Week High44.80
  • 52 Week High Date06/23/23
  • 52 Week Low2.35
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap4.085M
  • Shares Out1.57M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-71.81

KEY STATS

  • Open2.55
  • Day High2.82
  • Day Low2.50
  • Prev Close2.66
  • 52 Week High44.80
  • 52 Week High Date06/23/23
  • 52 Week Low2.35
  • 52 Week Low Date04/25/24
  • Market Cap4.085M
  • Shares Out1.57M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-71.81

RATIOS/PROFITABILITY

  • EPS (TTM)-35.76
  • P/E (TTM)-0.07
  • Fwd P/E (NTM)-0.14
  • EBITDA (TTM)-15.761M
  • ROE (TTM)-220.02%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-23,894.59%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bio Path Holdings Inc

 

Profile

MORE
Bio-Path Holdings, Inc. is a biotechnology company. The Company is engaged in developing DNAbilize, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous transfusion. DNAbilize, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body’s enzymes when circulating in vivo, incorporated inside of a lipid...
Peter Nielsen
Chairman of the Board, President, Chief Executive Officer, Co-Founder, Chief Financial Officer, Treasurer
Address
4710 BELLAIRE BOULEVARD, SUITE 210
Bellaire, TX
77401
United States

Top Peers

SYMBOLLASTCHG%CHG
PCSA
Processa Pharmaceuticals Inc
2.17-0.09-3.98%
ARTH
HOTH
Hoth Therapeutics Inc
1.21-0.02-1.55%
ATXI
Avenue Therapeutics Inc
4.78+0.01+0.21%
SONN
Sonnet Biotherapeutics Holdings Inc
1.86-0.06-3.12%